Login / Signup
San-Chi Chen
ORCID
Publication Activity (10 Years)
Years Active: 2018-2022
Publications (10 Years): 4
Top Topics
Metastatic Breast Cancer
Dna Repair
Study Protocol
Phase Ii
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
Medicine
Journal for immunotherapy of cancer
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Tom Wei-Wu Chen
,
Chia-Lang Hsu
,
Ruey-Long Hong
,
Jen-Chieh Lee
,
Koping Chang
,
Chih-Wei Yu
,
San-Chi Chen
,
Jhe-Cyuan Guo
,
Mei-Lu Chen
,
Meng-Chi Hsu
,
Ting-Fang Kung
,
Ann-Lii Cheng
,
Chueh-Chuan Yen
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research
28 (23) (2022)
Yi-Hsuan Lai
,
Kai-Che Tung
,
San-Chi Chen
Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report.
Medicine
101 (39) (2022)
Nai-Jung Chiang
,
Kien Thiam Tan
,
Li-Yuan Bai
,
Chin-Fu Hsiao
,
Chung-Yu Huang
,
Yi-Ping Hung
,
Chien-Jui Huang
,
San-Chi Chen
,
Yan-Shen Shan
,
Yee Chao
,
Yi-Hsiang Huang
,
I-Cheng Lee
,
Pei-Chang Lee
,
Yung-Yeh Su
,
Shu-Jen Chen
,
Chun-Nan Yeh
,
Li-Tzong Chen
,
Ming-Huang Chen
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.
Clinical cancer research : an official journal of the American Association for Cancer Research
28 (19) (2022)
Chien-Yi Hsu
,
Yu-Wen Su
,
San-Chi Chen
Sick sinus syndrome associated with anti-programmed cell death-1.
Journal for immunotherapy of cancer
6 (1) (2018)